Health insurances set premiums based on assumptions in patient behavior. When that behavior becomes subjective, health insurances should then include...
Read moreWe know medical costs lead to personal debt. Yet we continue adding to the costs, treating patients more and more....
Read morePeople ages 50 years and older and certain immunocompromised individuals who are at higher risk for severe disease, hospitalization and...
Read moreFor two months, the CDC allowed public comments on its draft revision of the opioid prescribing guidelines. They reveal that...
Read moreFor most people, visualizing what a million of anything looks like is an impossible task. The human brain just isn’t...
Read moreOne year into the COVID-19 pandemic, we found that more than 1 in 5 U.S. adults reported probable depression in...
Read moreThe COVID-19 pandemic has changed everyday life for many people in both trivial and profound ways, including how they look...
Read moreWhen medication abortion, or abortion with pills, was introduced to the U.S. in 2000, it offered a more accessible option...
Read moreData only tells one part of the story when it comes to understanding health policy. The full story is found...
Read moreResearchers have observed that the offspring of mice and other animals derive health benefits from passing through the vagina.
Read moreIn large part because of the pandemic, college leaders have expressed increased concern for the mental health of students.
Read moreDomesticated cats and dogs share approximately 85% of the same DNA as humans. And because both have been intimately associated...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy